Magnetic resonance spectroscopy in migraine: What have we learned so far?

Cephalalgia

Volumn 32, Issue 11, 2012, Pages 845-859

  Reyngoudt, Harmen ^a   Achten, Eric ^a   Paemeleire, Koen ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

1H MRS; 31P MRS; ATP; basilar type migraine; brain; brain metabolism; familial hemiplegic migraine; glutamate; lactate; migraine; migraine with aura; migraine with prolonged aura; migraine without aura; migrainous stroke; muscle metabolism; N acetylaspartate; phosphocreatine; sporadic hemiplegic migraine

Indexed keywords

4 AMINOBUTYRIC ACID; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CHOLINE; CREATINE; CREATINE PHOSPHATE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; LACTIC ACID; N ACETYLASPARTIC ACID; PHOSPHATE;

AEROBIC METABOLISM; ANTERIOR CINGULATE; BASAL GANGLION; BRAIN LEVEL; BRAIN METABOLISM; BRAIN REGION; CEREBELLUM; DISEASE SEVERITY; ENERGY METABOLISM; EXERCISE; FRONTAL LOBE; HEMISPHERE; HUMAN; HYPOTHALAMUS; INSULA; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; MIGRAINOUS INFARCTION; MITOCHONDRION; MUSCLE METABOLISM; NEUROBIOLOGY; OCCIPITAL CORTEX; OCCIPITAL LOBE; PH; PHENOTYPE; PHOSPHATE METABOLISM; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SPORADIC HEMIPLEGIC MIGRAINE; SYMPTOM; THALAMUS;

ADENOSINE TRIPHOSPHATE; ANIMALS; BRAIN; HUMANS; LACTIC ACID; MAGNETIC RESONANCE SPECTROSCOPY; MIGRAINE DISORDERS; MITOCHONDRIA; NERVE TISSUE PROTEINS;

EID: 84864714489     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102412452048     Document Type: Review

References (70)

1. Goadsby PJ. Pathophysiology of migraine. Neurol Clin. 2009 ; 27: 335-360
2. Arulmani U, Gupta S, VanDenBrink AM, Centurion D, Villalon CM, Saxena PR. Experimental migraine models and their relevance in migraine therapy. Cephalalgia. 2006 ; 26: 642-659
3. Sparaco M, Feleppa M, Lipton RB, Rapoport AM, Bigal ME. Mitochondrial dysfunction and migraine: evidence and hypotheses. Cephalalgia. 2006 ; 26: 361-372
4. Kemp GJ. Non-invasive methods for studying brain energy metabolism: what they show and what it means. Dev Neurosci. 2000 ; 22: 418-428
5. Welch KM, Levine SR, D'Andrea G, Schultz LR, Helpern JA. Preliminary observations on brain energy metabolism in migraine studied by in vivo phosphorus 31 NMR spectroscopy. Neurology. 1989 ; 39: 538-541
6. Welch KM, Levine SR, D'Andrea G, Helpern JA. Brain pH in migraine: an in vivo phosphorus-31 magnetic resonance spectroscopy study. Cephalalgia. 1988 ; 8: 273-277
7. Ramadan NM, Halvorson H, Vande-Linde A, Levine SR, Helpern JA, Welch KM. Low brain magnesium in migraine. Headache. 1989 ; 29: 590-593
8. Montagna P, Cortelli P, Monari L, Pierangeli G, Parchi P, Lodi R, et al. 31P-magnetic resonance spectroscopy in migraine without aura. Neurology. 1994 ; 44: 666-669
9. Montagna P. Magnetic resonance spectroscopy in migraine. Cephalalgia. 1995 ; 15: 323-327
10. Lodi R, Iotti S, Cortelli P, Pierangeli G, Cevoli S, Clementi V, et al. Deficient energy metabolism is associated with low free magnesium in the brains of patients with migraine and cluster headache. Brain Res Bull. 2001 ; 54: 437-441
11. Boska MD, Welch KM, Barker PB, Nelson JA, Schultz L. Contrasts in cortical magnesium, phospholipid and energy metabolism between migraine syndromes. Neurology. 2002 ; 58: 1227-1233
12. Reyngoudt H, Paemeleire K, Descamps B, De Deene Y, Achten E. 31P-MRS demonstrates a reduction in high-energy phosphates in the occipital lobe of migraine without aura patients. Cephalalgia. 2011 ; 31: 1243-1253
13. Barbiroli B, Montagna P, Cortelli P, Funicello R, Iotti S, Monari L, et al. Abnormal brain and muscle energy metabolism shown by 31P magnetic resonance spectroscopy in patients affected by migraine with aura. Neurology. 1992 ; 42: 1209-1214
14. Lodi R, Montagna P, Soriani S, Iotti S, Arnaldi C, Cortelli P, et al. Deficit of brain and skeletal muscle bioenergetics and low brain magnesium in juvenile migraine: an in vivo 31P magnetic resonance spectroscopy interictal study. Pediatr Res. 1997 ; 42: 866-871
15. Uncini A, Lodi R, Di Muzio A, Silvestri G, Servidei S, Lugaresi A, et al. Abnormal brain and muscle energy metabolism shown by 31P-MRS in familial hemiplegic migraine. J Neurol Sci. 1995 ; 129: 214-222
16. Barbiroli B, Montagna P, Cortelli P, Martinelli P, Sacquegna T, Zaniol P, Lugaresi E. Complicated migraine studied by phosphorus magnetic resonance spectroscopy. Cephalalgia. 1990 ; 10: 263-272
17. Sacquegna T, Lodi R, De Carolis P, Tinuper P, Cortelli P, Zaniol P, et al. Brain energy metabolism studied by 31P-MR spectroscopy in a case of migraine with prolonged aura. Acta Neurol Scand. 1992 ; 86: 376-380
18. Bresolin N, Martinelli P, Barbiroli B, Zaniol P, Ausenda C, Montagna P, et al. Muscle mitochondrial DNA deletion and 31P-NMR spectroscopy alterations in a migraine patient. J Neurol Sci. 1991 ; 104: 182-189
19. Schulz UG, Blamire AM, Corkill RG, Davies P, Styles P, Rothwell PM. Association between cortical metabolite levels and clinical manifestations of migrainous aura: an MR-spectroscopy study. Brain. 2007 ; 130: 3102-3110
20. Schulz UG, Blamire AM, Davies P, Styles P, Rothwell PM. Normal cortical energy metabolism in migrainous stroke: A 31P-MR spectroscopy study. Stroke. 2009 ; 40: 3740-3744
21. Eleff SM, Barker PB, Blackband SJ, Chatham JC, Lutz NW, Johns DR, et al. Phosphorus magnetic resonance spectroscopy of patients with mitochondrial cytopathies demonstrates decreased levels of brain phosphocreatine. Ann Neurol. 1990 ; 27: 626-630
22. Barbiroli B, Montagna P, Martinelli P, Lodi R, Iotti S, Cortelli P, et al. Defective brain energy metabolism shown by in vivo 31P MR spectroscopy in 28 patients with mitochondrial cytopathies. J Cereb Blood Flow Metab. 1993 ; 13: 469-474
23. Grimaldi D, Tonon C, Cevoli S, Pierangeli G, Malucelli E, Rizzo G, et al. Clinical and neuroimaging evidence of interictal cerebellar dysfunction in FHM2. Cephalalgia. 2010 ; 30: 552-559
24. Lodi R, Kemp GJ, Montagna P, Pierangeli G, Cortelli P, Iotti S, et al. Quantitative analysis of skeletal muscle bioenergetics and proton efflux in migraine and cluster headache. J Neurol Sci. 1997 ; 146: 73-80
25. Arnold DL, Matthews PM, Radda GK. Metabolic recovery after exercise and the assessment of mitochondrial function in vivo in human skeletal muscle by means of 31P NMR. Magn Reson Med. 1984 ; 1: 307-315
26. Alger JR. Quantitative proton magnetic resonance spectroscopy and spectroscopic imaging of the brain: a didactic review. Top Magn Reson Imaging. 2010 ; 21: 115-128
27. Watanabe H, Kuwabara T, Ohkubo M, Tsuji S, Yuasa T. Elevation of cerebral lactate detected by localized 1H-magnetic resonance spectroscopy in migraine during the interictal period. Neurology. 1996 ; 47: 1093-1095
28. Sandor PS, Dydak U, Schoenen J, Kollias SS, Hess K, Boesiger P, Agosti RM. MR-spectroscopic imaging during visual stimulation in subgroups of migraine with aura. Cephalalgia. 2005 ; 25: 507-518
29. Lin DD, Crawford TO, Barker PB. Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease. AJNR Am J Neuroradiol. 2003 ; 24: 33-41
30. Reyngoudt H, De Deene Y, Descamps B, Paemeleire K, Achten E. (1)H-MRS of brain metabolites in migraine without aura: absolute quantification using the phantom replacement technique. MAGMA. 2010 ; 23: 227-241
31. Reyngoudt H, Paemeleire K, Dierickx A, Descamps B, Vandemaele P, De Deene Y, Achten E. Does visual cortex lactate increase following photic stimulation in migraine without aura patients? A functional (1)H-MRS study. J Headache Pain. 2011 ; 12: 295-302
32. Pellerin L, Pellegri G, Bittar PG, Charnay Y, Bouras C, Martin JL, et al. Evidence supporting the existence of an activity-dependent astrocyte-neuron lactate shuttle. Dev Neurosci. 1998 ; 20: 291-299
33. Tong CK, Chesler M. Modulation of spreading depression by changes in extracellular pH. J Neurophysiol. 2000 ; 84: 2449-2457
34. Sarchielli P, Tarducci R, Presciutti O, Gobbi G, Pelliccioli GP, Stipa G, et al. Functional 1H-MRS findings in migraine patients with and without aura assessed interictally. Neuroimage. 2005 ; 24: 1025-1031
35. Taylor DL, Davies SE, Obrenovitch TP, Doheny MH, Patsalos PN, Clark JB, Symon L. Investigation into the role of N-acetylaspartate in cerebral osmoregulation. J Neurochem. 1995 ; 65: 275-281
36. Gu T, Ma XX, Xu YH, Xiu JJ, Li CF. Metabolite concentration ratios in thalami of patients with migraine and trigeminal neuralgia measured with 1H-MRS. Neurol Res. 2008 ; 30: 229-233
37. Dichgans M, Herzog J, Freilinger T, Wilke M, Auer DP. 1H-MRS alterations in the cerebellum of patients with familial hemiplegic migraine type 1. Neurology. 2005 ; 64: 608-613
38. Jacob A, Mahavish K, Bowden A, Smith ET, Enevoldson P, White RP. Imaging abnormalities in sporadic hemiplegic migraine on conventional MRI, diffusion and perfusion MRI and MRS. Cephalalgia. 2006 ; 26: 1004-1009
39. Toldo I, Cecchin D, Sartori S, Calderone M, Mardari R, Cattelan F, et al. Multimodal neuroimaging in a child with sporadic hemiplegic migraine: a contribution to understanding pathogenesis. Cephalalgia. 2011 ; 31: 751-756
40. Russell MB, Ducros A. Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol. 2011 ; 10: 457-470
41. Pietrobon D. Familial hemiplegic migraine. Neurotherapeutics. 2007 ; 4: 274-284
42. Anttila V, Stefansson H, Kallela M, Todt U, Terwindt GM, Calafato MS, et al. Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nat Genet. 2010 ; 42: 869-873
43. Ligthart L, de Vries B, Smith AV, Ikram MA, Amin N, Hottenga JJ, et al. Meta-analysis of genome-wide association for migraine in six population-based European cohorts. Eur J Hum Genet. 2011 ; 19: 901-907
44. Chasman DI, Schurks M, Anttila V, de Vries B, Schminke U, Launer LJ, et al. Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nat Genet. 2011 ; 43: 695-698
45. Prescot A, Becerra L, Pendse G, Tully S, Jensen E, Hargreaves R, et al. Excitatory neurotransmitters in brain regions in interictal migraine patients. Mol Pain. 2009 ; 5: 34-34
46. Reyngoudt H, Claeys T, Vlerick L, Verleden S, Acou M, Deblaere K, et al. Age-related differences in metabolites in the posterior cingulate cortex and hippocampus of normal ageing brain: A (1)H-MRS study. Eur J Radiol. 2011 ; 81: e223 - e231
47. Wang X, Wang H, Xia Y, Jiang H, Shen L, Wang S, et al. A neuropathological study at autopsy of early onset spinocerebellar ataxia 6. J Clin Neurosci. 2010 ; 17: 751-755
48. Macri MA, Garreffa G, Giove F, Ambrosini A, Guardati M, Pierelli F, et al. Cerebellar metabolite alterations detected in vivo by proton MR spectroscopy. Magn Reson Imaging. 2003 ; 21: 1201-1206
49. Chawalparit O, Siriacharwattana W. Evidence of vascular compromise over the visual cortex during migrainous headache: a case report with MRI study. J Med Assoc Thai. 2010 ; 93: 749-752
50. Afridi SK, Goadsby PJ. Neuroimaging of migraine. Curr Pain Headache Rep. 2006 ; 10: 221-224
51. Henderson LA, Gandevia SC, Macefield VG. Somatotopic organization of the processing of muscle and cutaneous pain in the left and right insula cortex: a single-trial fMRI study. Pain. 2007 ; 128: 20-30
52. Sandor PS, Mascia A, Seidel L, de Pasqua V, Schoenen J. Subclinical cerebellar impairment in the common types of migraine: a three-dimensional analysis of reaching movements. Ann Neurol. 2001 ; 49: 668-672
53. Yilmaz-Kusbeci O, Gocmen-Mas N, Yucel A, Karabekir HS, Ertekin T, Yazici AC. Evaluation of cerebellar and cerebral volume in migraine with aura: a stereological study. Cerebellum. 2010 ; 9: 345-351
54. Wang SJ, Lirng JF, Fuh JL, Chen JJ. Reduction in hypothalamic 1H-MRS metabolite ratios in patients with cluster headache. J Neurol Neurosurg Psychiatry. 2006 ; 77: 622-625
55. Prichard J, Rothman D, Novotny E, Petroff O, Kuwabara T, Avison M, et al. Lactate rise detected by 1H NMR in human visual cortex during physiologic stimulation. Proc Natl Acad Sci U S A. 1991 ; 88: 5829-5831
56. Sappey-Marinier D, Calabrese G, Fein G, Hugg JW, Biggins C, Weiner MW. Effect of photic stimulation on human visual cortex lactate and phosphates using 1H and 31P magnetic resonance spectroscopy. J Cereb Blood Flow Metab. 1992 ; 12: 584-592
57. Frahm J, Kruger G, Merboldt KD, Kleinschmidt A. Dynamic uncoupling and recoupling of perfusion and oxidative metabolism during focal brain activation in man. Magn Reson Med. 1996 ; 35: 143-148
58. Mangia S, Tkac I, Gruetter R, Van De Moortele PF, Giove F, Maraviglia B, Ugurbil K. Sensitivity of single-voxel 1H-MRS in investigating the metabolism of the activated human visual cortex at 7 T. Magn Reson Imaging. 2006 ; 24: 343-348
59. Mangia S, Tkac I, Gruetter R, Van de Moortele PF, Maraviglia B, Ugurbil K. Sustained neuronal activation raises oxidative metabolism to a new steady-state level: evidence from 1H NMR spectroscopy in the human visual cortex. J Cereb Blood Flow Metab. 2007 ; 27: 1055-1063
60. Mangia S, Tkac I, Logothetis NK, Gruetter R, Van de Moortele PF, Ugurbil K. Dynamics of lactate concentration and blood oxygen level-dependent effect in the human visual cortex during repeated identical stimuli. J Neurosci Res. 2007 ; 85: 3340-3346
61. Bottomley PA, Hardy CJ. Rapid, reliable in vivo assays of human phosphate metabolites by nuclear magnetic resonance. Clin Chem. 1989 ; 35: 392-395
62. Iles RA, Stevens AN, Griffiths JR, Morris PG. Phosphorylation status of liver by 31P-n.m.r. spectroscopy, and its implications for metabolic control. A comparison of 31P-n.m.r. spectroscopy (in vivo and in vitro) with chemical and enzymic determinations of ATP, ADP and Pi. Biochem J. 1985 ; 229: 141-151
63. Pietz J, Rupp A, Ebinger F, Rating D, Mayatepek E, Boesch C, Kreis R. Cerebral energy metabolism in phenylketonuria: findings by quantitative In vivo 31P MR spectroscopy. Pediatr Res. 2003 ; 53: 654-662
64. Ma Z, Wang SJ, Li CF, Ma XX, Gu T. Increased metabolite concentration in migraine rat model by proton MR spectroscopy in vivo and ex vivo. Neurol Sci. 2008 ; 29: 337-342
65. Schoenen J, Lenaerts M, Bastings E. High-dose riboflavin as a prophylactic treatment of migraine: results of an open pilot study. Cephalalgia. 1994 ; 14: 328-329
66. Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology. 1998 ; 50: 466-470
67. Rozen TD, Oshinsky ML, Gebeline CA, Bradley KC, Young WB, Shechter AL, et al. Open label trial of coenzyme Q10 as a migraine preventive. Cephalalgia. 2002 ; 22: 137-141
68. Sandor PS, Di Clemente L, Coppola G, Saenger U, Fumal A, Magis D, et al. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology. 2005 ; 64: 713-715
69. Di Lorenzo C, Pierelli F, Coppola G, Grieco GS, Rengo C, Ciccolella M, et al. Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs. Neurology. 2009 ; 72: 1588-1594
70. Welch KM. Migraine. A biobehavioral disorder. Arch Neurol. 1987 ; 44: 323-327